表紙
市場調查報告書

微射流的全球市場 - 各材料,用途,地區的規模,佔有率,及趨勢分析與各市場區隔的預測:2019年∼2026年

Microfluidics Market Size, Share & Trends Analysis Report By Material (Polymer, Glass, Silicon, Metal, Ceramic), By Application (Pharmaceutical, In-Vitro diagnostics), By Region, And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 370429
出版日期 內容資訊 英文 122 Pages
商品交期: 2-3個工作天內
價格
Back to Top
微射流的全球市場 - 各材料,用途,地區的規模,佔有率,及趨勢分析與各市場區隔的預測:2019年∼2026年 Microfluidics Market Size, Share & Trends Analysis Report By Material (Polymer, Glass, Silicon, Metal, Ceramic), By Application (Pharmaceutical, In-Vitro diagnostics), By Region, And Segment Forecasts, 2019 - 2026
出版日期: 2019年06月07日內容資訊: 英文 122 Pages
簡介

全球微射流市場在2019年∼2026年間預測將以18.07%的年複合成長率成長,2026年達到134億美元。使晶載的生物化學分析成為可能的數位微射流等的技術提升,認為是該市場的成長要素。

本報告提供全球微射流市場的相關調查,市場趨勢及預測,各用途、原料、地區的市場分析,競爭情形,主要企業的簡介等資訊。

第1章 調查方法及範圍

第2章 摘要整理

  • 市場預測
  • 市場區隔預測

第3章 市場變動,趨勢,及範圍

  • 各市場系統預測
  • 市場區隔
  • 洞察及成長預測的製圖
  • 微射流市場分析工具

第4章 微射流市場:各用途的估計及趨勢分析

  • 各用途趨勢分析
  • 醫藥品
    • 基因學
    • 蛋白質體學
    • 細胞為基礎的化驗等
  • 體外診斷(IVD)
    • POC
    • 臨床
    • 環境及產業
  • 醫療設備

第5章 微射流市場:各原料的估計及趨勢分析

  • 各原料趨勢分析
  • 聚合物
  • 玻璃酒杯
  • 其他

第6章 微射流市場:各地區的估計及趨勢分析

  • 微射流的市場佔有率,各地區,2018年及2026年
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 印度
    • 中國
    • 日本
  • 南美
    • 巴西
    • 墨西哥
  • 中東及非洲地區
    • 南非

第7章 競爭情形

  • 主要各打入市場業者:最近的開發,及影響分析
  • 策略架構
  • 業者情勢
  • 企業市場情況分析(收益,地區的存在,產品系列策略,就業人員的能力)
  • 企業簡介

第8章 建議

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-056-9

The global microfluidics market size is expected to reach USD 13.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 18.07% during the forecast period. Introduction of improved technology, such as digital microfluidics, which enables on-chip biochemical analysis, is anticipated to fuel the growth.

Industry players are introducing newer sampling technologies to meet the demand for screening a huge number of biological samples. For instance, in November 2017, Dolomite introduced its new droplet-based microfluidics platform named Nadia single cell platform for single cell research.

Moreover, researchers are continuously striving to come up with improved sample droplet production techniques. For instance, Columbia University introduced the picoliter fluid dispensation technology. This lab-on-chip technology could deliver sample volume less than 50 nL. Integrating microfluidics with multiplexed sensing technology allows multiple sample analytical application.

Novel drug delivery systems require administration of the drug in the form of nanoparticles, thereby reducing the onset of action. Devices such as microneedles, pumps, and inhalers are expected to experience fastest growth during the forecasted period.

The market players engage in mergers and acquisitions, partnerships, and collaborations among the competitors for technological advancements. For instance, in July 2017 Fluidigm Corporation and Ascendas Genomics underwent into strategic partnership to develop and commercialize molecular diagnostic systems and assays using microfluidic technologies in China.

Further key findings from the study suggest:

  • In Vitro Diagnostic (IVD) segment led the application segment owing to the increasing adoption of microfluidics. Moreover, the leaders in the diagnostics sector, such as Abbott, Roche, and Danaher are encouraging the use of newer microfluidics technologies, such as the monodisperse bubbles/drops
  • Polymers held the largest revenue share in 2018. Polymers offer better temperature control than glass. However, silicon material is expected to witness the fastest growth owing to the dominance of point-of-care diagnostics in the microfluidics market. Moreover, growing demand for faster results with minimally invasive tools is expected to further boost the growth
  • North America led the market in 2018, attributed to the presence of strong research capital, introduction of improved sample volume screening techniques, and presence of dominant market players
  • Asia Pacific is expected to witness the fastest CAGR owing to the increasing aging population, repeated hospital visits, presence of untapped market, and the low cost of labor. These factors have attracted many international players to establish their research laboratories in countries like India and China

Some key players are Illumina, Inc.; Agilent Technologies; Caliper Life Sciences (acquired by PerkinElmer, Inc.); Cepheid; Danaher Corporation; Life Technologies Corporation (acquired by Thermo Fisher Scientific, Inc.); Bio-Rad Laboratories, Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Application
    • 1.1.2 Material
    • 1.1.3 Regional Scope
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Europe
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Application
    • 2.2.2 Material
    • 2.2.3 Region
    • 2.2.4 Competitive Insights
  • 2.3 Market Outlook

Chapter 3 Market Variables, Trends& Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market segmentation
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing demand for low volume sample analysis
      • 3.2.1.2 Growing penetration of microfluidics in diagnostics market
      • 3.2.1.3 Introduction of advanced technologies
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High operational cost
      • 3.2.2.2 Interfacing and integration
      • 3.2.2.3 Complex fabrication process
  • 3.3 Penetration & growth prospect mapping
  • 3.4 Microfluidics Market Analysis Tools
    • 3.4.1 PEST - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.4.2 Industry Analysis - Porter's
    • 3.4.3 Major Delas And Strategic Analysis
      • 3.4.3.1 Joint ventures, mergers and acquisition
      • 3.4.3.2 Licensing & partnerships, technology collaborations

Chapter 4 Microfluidics Market: Application Estimates & Trend Analysis

  • 4.1 Microfluidics market: application movement analysis
  • 4.2 Pharmaceuticals
    • 4.2.1 Pharmaceuticals Market, 2015 - 2026 (USD Million)
    • 4.2.2 Genomics
      • 4.2.2.1 Genomics market, 2015 - 2026 (USD Million)
    • 4.2.3 Proteomics
      • 4.2.3.1 Proteomics market, 2015 - 2026 (USD Million)
    • 4.2.4 Cell based assays and others
      • 4.2.4.1 Cell-based assays and others, market, 2015 - 2026 (USD Million)
  • 4.3 In-vitro Diagnostics (IVD)
    • 4.3.1 IVD Market, 2015 - 2026 (USD Million)
    • 4.3.2 POC
      • 4.3.2.1 POC market, 2015 - 2026 (USD Million)
    • 4.3.3 Clinical
      • 4.3.3.1 Clinical market, 2015 - 2026 (USD Million)
    • 4.3.4 Environmental And Industrial
      • 4.3.4.1 Environmental and industrial market, 2015 - 2026 (USD Million)
  • 4.4 Medical Devices
    • 4.4.1 Medical Devices Market, 2015 - 2026 (USD Million)

Chapter 5 Microfluidics Market: Material Estimates & Trend Analysis

  • 5.1 Microfluidics market: Material movement analysis
  • 5.2 Polymer
    • 5.2.1 Polymer Market, 2015 - 2026 (USD Million)
  • 5.3 Glass
    • 5.3.1 Glass Market, 2015 - 2026 (USD Million)
  • 5.4 Silicon
    • 5.4.1 Silicon Market, 2015 - 2026 (USD Million)
  • 5.5 Others
    • 5.5.1 Others Market, 2015 - 2026 (USD Million)

Chapter 6 Microfluidics Market: Regional Estimates & Trend Analysis

  • 6.1 Microfluidics market share, by region, 2018 & 2026
  • 6.2 North America
    • 6.2.1 North America Microfluidics Market, 2015 - 2026 (USD Million)
    • 6.2.2 U.S
      • 6.2.2.1 U.S microfluidics market, 2015 - 2026 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada microfluidics market, 2015 - 2026 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Microfluidics Market, 2015 - 2026 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. microfluidics market, 2015 - 2026 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany microfluidics market, 2015 - 2026 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France microfluidics market, 2015 - 2026 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Microfluidics Market, 2015 - 2026 (USD Million)
    • 6.4.2 India
      • 6.4.2.1 India microfluidics market, 2015 - 2026 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China microfluidics market, 2015 - 2026 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Japan microfluidics market, 2015 - 2026 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Microfluidics Market, 2015 - 2026 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil microfluidics market, 2015 - 2026 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico microfluidics market, 2015 - 2026 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA Microfluidics Market, 2015 - 2026 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa microfluidics market, 2015 - 2026 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2 Strategy Framework
  • 7.3 Vendor Landscape
    • 7.3.1 List Of Key Distributors And Channel Partners
    • 7.3.2 Strategy Mapping
      • 7.3.2.1 Partnerships
      • 7.3.2.2 Launch of New Product
      • 7.3.2.3 Merger & Acquisition
      • 7.3.2.4 Geographical Expansion
      • 7.3.2.5 Marketing & Promotions
  • 7.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
  • 7.5 Company Profiles
    • 7.5.1 Illumina, Inc.
      • 7.5.1.1 Company overview
      • 7.5.1.2 Financial performance
      • 7.5.1.3 Product benchmarking
      • 7.5.1.4 Strategic initiatives
      • 7.5.1.5 SWOT analysis
    • 7.5.2 Agilent Technologies
      • 7.5.2.1 Company overview
      • 7.5.2.2 Financial performance
      • 7.5.2.3 Product benchmarking
      • 7.5.2.4 Strategic initiatives
      • 7.5.2.5 SWOT analysis
    • 7.5.3 Caliper Life Sciences
      • 7.5.3.1 Company overview
      • 7.5.3.2 Financial performance
      • 7.5.3.3 Product benchmarking
      • 7.5.3.4 Strategic initiatives
      • 7.5.3.5 SWOT analysis
    • 7.5.4 Cepheid
      • 7.5.4.1 Company overview
      • 7.5.4.2 Financial performance
      • 7.5.4.3 Product benchmarking
      • 7.5.4.4 Strategic initiatives
      • 7.5.4.5 SWOT analysis
    • 7.5.5 Danaher Corporation
      • 7.5.5.1 Company overview
      • 7.5.5.2 Financial performance
      • 7.5.5.3 Product benchmarking
      • 7.5.5.4 Strategic initiatives
      • 7.5.5.5 SWOT analysis
    • 7.5.6 Life Technologies Corporation
      • 7.5.6.1 Company overview
      • 7.5.6.2 Financial performance
      • 7.5.6.3 Product benchmarking
      • 7.5.6.4 Strategic initiatives
      • 7.5.6.5 SWOT analysis
    • 7.5.7 Bio-Rad Laboratories, Inc.
      • 7.5.7.1 Company overview
      • 7.5.7.2 Financial performance
      • 7.5.7.3 Product benchmarking
      • 7.5.7.4 Strategic initiatives
      • 7.5.7.5 SWOT analysis
    • 7.5.8 Abbott Laboratories
      • 7.5.8.1 Company overview
      • 7.5.8.2 Financial performance
      • 7.5.8.3 Product benchmarking
      • 7.5.8.4 Strategic initiatives
      • 7.5.8.5 SWOT analysis
    • 7.5.9 F. HOFFMANN-LA ROCHE LTD
      • 7.5.9.1 Company overview
      • 7.5.9.2 Financial performance
      • 7.5.9.3 Product benchmarking
      • 7.5.9.4 Strategic initiatives
      • 7.5.9.5 SWOT analysis
    • 7.5.10 Fluidigm Corporation
      • 7.5.10.1 Company overview
      • 7.5.10.2 Financial performance
      • 7.5.10.3 Product benchmarking
      • 7.5.10.4 Strategic initiatives
      • 7.5.10.5 SWOT analysis

Chapter 8 Recommendations

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of abbreviation
  • TABLE 8 Joint ventures, mergers and acquisition
  • TABLE 9 Licensing & partnerships, technology collaborations
  • TABLE 10 North America microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 11 North America microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 12 North America pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 13 North America IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 14 North America microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 15 U.S. microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 16 U.S. pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 17 U.S. IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 18 U.S. microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 19 Canada microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 20 Canada pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 21 Canada IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 22 Canada microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 23 Europe microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 24 Europe microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 25 Europe pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 26 Europe IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 27 Europe microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 28 U.K. microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 29 U.K. pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 30 U.K. IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 31 U.K. microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 32 Germany microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 33 Germany pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 34 Germany IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 35 Germany microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 36 France microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 37 France pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 38 France IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 39 France microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 40 Asia Pacific microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 41 Asia Pacific microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 42 Asia Pacific pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 43 Asia Pacific IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 44 Asia Pacific microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 45 India microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 46 India pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 47 India IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 48 India microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 49 China microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 50 China pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 51 China IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 52 China microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 53 Japan microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 54 Japan pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 55 Japan IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 56 Japan microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 57 Latin America microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 58 Latin America microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 59 Latin America pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 60 Latin America IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 61 Latin America microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 62 Brazil microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 63 Brazil pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 64 Brazil IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 65 Brazil microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 66 Mexico microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 67 Mexico pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 68 Mexico IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 69 Mexico microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 70 MEA microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 71 MEA microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 72 MEA pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 73 MEA IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 74 MEA microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
  • TABLE 75 South Africa microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 76 South Africa pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 77 South Africa IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
  • TABLE 78 South Africa microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market outlook
  • FIG. 2 Market trends & scope
  • FIG. 3 Market segmentation
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 PEST - SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Microfluidics market application outlook key takeaways
  • FIG. 10 Microfluidics market: application movement analysis
  • FIG. 11 Global pharmaceutical market, 2015 - 2026 (USD Million )
  • FIG. 12 Global genomics market, 2015 - 2026 (USD Million)
  • FIG. 13 Global proteomics market, 2015 - 2026 (USD Million)
  • FIG. 14 Cell-based assays and others market, 2015 - 2026 (USD Million)
  • FIG. 15 Global IVD market, 2015 - 2026 (USD Million )
  • FIG. 16 Global POC Market, 2015 - 2026 (USD Million)
  • FIG. 17 Global clinical market, 2015 - 2026 (USD Million)
  • FIG. 18 Environmental and industrial market, 2015 - 2026 (USD Million)
  • FIG. 19 Global medical devices market, 2015 - 2026 (USD Million)
  • FIG. 20 Microfluidics market material outlook key takeaways
  • FIG. 21 Microfluidics market: material movement analysis
  • FIG. 22 Global polymer market, 2015 - 2026 (USD Million )
  • FIG. 23 Global glass market, 2015 - 2026 (USD Million )
  • FIG. 24 Global silicon market, 2015 - 2026 (USD Million )
  • FIG. 25 Global others market, 2015 - 2026 (USD Million )
  • FIG. 26 Regional market place: Key takeaways
  • FIG. 27 Regional outlook, 2018 & 2026
  • FIG. 28 North America microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 29 U.S. microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 30 Canada microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 31 Europe microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 32 U.K. microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 33 Germany microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 34 France microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 35 Asia Pacific microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 36 India microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 37 China microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 38 Japan microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 39 Latin America microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 40 Brazil microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 41 Mexico microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 42 MEA microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 43 South Africa microfluidics market, 2015 - 2026 (USD Million )
  • FIG. 44 Recent development & impact analysis by key market participants
  • FIG. 45 Strategy framework
  • FIG. 46 Strategy mapping
Back to Top